Various companies report quarterly earnings and financial results

Several companies released quarterly financial results and earnings reports.

Sutro Biopharma reported an EPS of ($0.14), missing analyst estimates of ($0.19), with quarterly revenue of $9.84 million. Legend Biotech saw its price target lowered by TD Cowen from $29.00 to $24.00, while the company maintains a consensus rating of 'Hold'.

Bravura Solutions Limited reported a strong 2026 fiscal year, with revenue growing 10% to $283.6 million and cash EBITDA increasing 76% to $77.1 million. Palisade Bio met consensus expectations with an EPS of ($0.05) on revenue of $0.50 million.

BridgeBio Pharma reported an EPS of ($0.78), missing the consensus estimate of ($0.58), though revenue of $243.68 million exceeded the $220.91 million estimate. Bionano Genomics also held an earnings call regarding its second quarter 2026 financial results.